RT Journal Article
SR Electronic
T1 Artificial intelligence for rapid identification of the coronavirus disease 2019 (COVID-19)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.12.20062661
DO 10.1101/2020.04.12.20062661
A1 Mei, Xueyan
A1 Lee, Hao-Chih
A1 Kaiyue-Diao,
A1 Huang, Mingqian
A1 Lin, Bin
A1 Liu, Chenyu
A1 Xie, Zongyu
A1 Ma, Yixuan
A1 Robson, Philip M.
A1 Chung, Michael
A1 Bernheim, Adam
A1 Mani, Venkatesh
A1 Calcagno, Claudia
A1 Li, Kunwei
A1 Li, Shaolin
A1 Shan, Hong
A1 Lv, Jian
A1 Zhao, Tongtong
A1 Xia, Junli
A1 Long, Qihua
A1 Steinberger, Sharon
A1 Jacobi, Adam
A1 Deyer, Timothy
A1 Luksza, Marta
A1 Liu, Fang
A1 Little, Brent P.
A1 Fayad, Zahi A.
A1 Yang, Yang
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.12.20062661.abstract
AB The coronavirus disease 2019 (COVID-19) outbreak that originated in Wuhan, China has rapidly propagated due to widespread person-to-person transmission and has resulted in over 1,133,758 cases in 197 countries with a total of 62,784 deaths as of April 5, 2020. Laboratory confirmation of SARS-CoV-2 is performed with a virus-specific reverse transcriptase polymerase chain reaction (RT-PCR) test. This test can take up to two days to complete, and, due to the possibility of false negatives, serial testing may be required to reliably exclude infection. A current supply shortage of RT-PCR test kits compounds the shortcomings of entrusting diagnosis to the PCR test alone and underscores the urgent need to provide alternative methods for the rapid and accurate diagnosis of SARS-CoV-2 patients. Chest computed tomography (CT) is a valuable component in the evaluation of patients with suspected SARS-CoV-2 infection. Nevertheless, CT alone may have limited negative predictive value to fully exclude infection, because of the normal radiologic findings in some early disease patients. In this study, we use artificial intelligence (AI) algorithms to integrate chest CT findings with clinical symptoms, exposure history, and/or laboratory testing to more accurately and rapidly diagnose SARS-CoV-2 (+) patients. We included 905 RT-PCR confirmed patients. 419 (46.2%) tested positive for SARS-CoV-2 by laboratory-confirmed real-time RT-PCR assay and next-generation sequencing, while 486 patients (53.8%) tested negative (confirmed by at least two additional negative RT-PCR tests and clinical observation). The proposed AI system achieved an AUC of 0.92 and performed equally well in sensitivity compared to a senior thoracic radiologist on a testing set of 279 cases. The AI system also improved the detection of RT-PCR positive SARS-CoV-2 patients who presented with normal CTs, correctly identifying 17/25 (68%) patients, whereas all 25 RT-PCR SARS-CoV-2-positive CT-normal patients were classified as SARS-CoV-2 negative by radiologists.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used in this study are not publicly available due to ethical considerations.